InvestSMART

Genera Biosystems Limited (ASX: GBI) - Announcements

DELISTED - Current share price for GBI : $0.160

ASX company news and announcements for Genera Biosystems Limited (GBI) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Genera Biosystems Limited (GBI) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Genera Biosystems Limited (GBI), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Genera Biosystems Limited (GBI)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Placement of Final Tranche of Unlisted Convertible Notes 2 Mar 2015 10:11AM n/a $0.160 n/a
- Appendix 4D and Half Year Financial Report 27 Feb 2015 2:59PM n/a $0.160 n/a
- Appendix 4C - quarterly 30 Jan 2015 9:01AM n/a $0.160 n/a
- Reinstatement to Official Quotation 19 Dec 2014 9:54AM $0.200 $0.160 fallen by 20%
- Suspension from Official Quotation 12 Dec 2014 9:37AM $0.220 $0.160 fallen by 27.27%
- Trading Halt 10 Dec 2014 9:18AM $0.220 $0.160 fallen by 27.27%
- Response to Appendix 4C Query 1 Dec 2014 9:59AM $0.240 $0.160 fallen by 33.33%
- Response to Appendix 4C Query 1 Dec 2014 9:59AM $0.240 $0.160 fallen by 33.33%
- Appendix 4C - quarterly 31 Oct 2014 1:58PM $0.250 $0.160 fallen by 36%
- Beckman Coulter SCC and CEO Appointment 2 Oct 2014 9:17AM $0.280 $0.160 fallen by 42.86%
- Genera Lodges TGA Application 3 Sep 2014 8:54AM $0.270 $0.160 fallen by 40.74%
- 2014 Appendix 4E and Annual Report 1 Sep 2014 9:00AM $0.290 $0.160 fallen by 44.83%
- Strategic Commercial Alliance 18 Aug 2014 8:50AM $0.290 $0.160 fallen by 44.83%
- Appendix 4C - quarterly 31 Jul 2014 11:09AM $0.295 $0.160 fallen by 45.76%
- Strategic Review Outcome 30 Jun 2014 8:47AM $0.340 $0.160 fallen by 52.94%
- Health Canada approves HPV test as Primary Screening Tool 16 Jun 2014 10:03AM $0.340 $0.160 fallen by 52.94%
- Response to ASX Price Query 12 Jun 2014 1:01PM $0.260 $0.160 fallen by 38.46%
- Placement and Proposed Spin-Out of NextGen Q-Sand Assets 19 May 2014 10:04AM $0.185 $0.160 fallen by 13.51%
- Response to ASX Price Query 15 May 2014 2:49PM $0.185 $0.160 fallen by 13.51%
- Appendix 4C - quarterly 30 Apr 2014 11:08AM $0.150 $0.160 risen by 6.67%
- Australian MSAC recommends HPV testing to replace Pap 29 Apr 2014 11:39AM $0.150 $0.160 risen by 6.67%
- FDA Advisory Committee Decision 17 Mar 2014 2:29PM $0.090 $0.160 risen by 77.78%
- Appendix 4D and Half Year Financial Report 28 Feb 2014 4:57PM $0.100 $0.160 risen by 60%
- Appendix 4C - quarterly 31 Jan 2014 11:42AM $0.130 $0.160 risen by 23.08%
- Appendix 4C - quarterly 31 Oct 2013 3:13PM $0.098 $0.160 risen by 63.27%

176 - 200 of 275 results

Page 8 of 11

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.